Kristen E. Nailor
Research Triangle Park
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Kristen E. Nailor.
Bioorganic & Medicinal Chemistry Letters | 2009
Kyle Allen Emmitte; George M. Adjebang; C. Webb Andrews; Jennifer G. Badiang Alberti; Ramesh Bambal; Stanley D. Chamberlain; Ronda G. Davis-Ward; Hamilton D. Dickson; Daniel F. Hassler; Keith R. Hornberger; Jeffrey R. Jackson; Kevin Wayne Kuntz; Timothy J. Lansing; Robert A. Mook; Kristen E. Nailor; Mark Andrew Pobanz; Stephon C. Smith; Chiu-Mei Sung; Mui Cheung
A series of thiophene PLK1 inhibitors was optimized for increased solubility and reduced protein binding through the appendage of basic amine functionality. Interesting selectivity between PLK1 and PLK3 was also obtained through these modifications.
Bioorganic & Medicinal Chemistry Letters | 2009
Kyle Allen Emmitte; C. Webb Andrews; Jennifer Gabriel Badiang; Ronda G. Davis-Ward; Hamilton D. Dickson; David H. Drewry; Holly Kathleen Emerson; Andrea H. Epperly; Daniel F. Hassler; Victoria B. Knick; Kevin Wayne Kuntz; Timothy J. Lansing; James A. Linn; Robert A. Mook; Kristen E. Nailor; James Michael Salovich; Glenn M. Spehar; Mui Cheung
The discovery and development of a series of thiophenes as potent and selective inhibitors of PLK is described. Identification and characterization of 2, a useful in vitro PLK inhibitor tool compound, is also presented.
Bioorganic & Medicinal Chemistry Letters | 2009
Kyle Allen Emmitte; Brian John Wilson; Erich W. Baum; Holly Kathleen Emerson; Kevin Wayne Kuntz; Kristen E. Nailor; James Michael Salovich; Stephon C. Smith; Mui Cheung; Roseanne M. Gerding; Kirk L. Stevens; David E. Uehling; Robert A. Mook; Ganesh S. Moorthy; Scott Howard Dickerson; Anne M. Hassell; M. Anthony Leesnitzer; Lisa M. Shewchuk; Arthur Groy; Jason L. Rowand; Kelly Anderson; Charity Atkins; Jingsong Yang; Peter Sabbatini; Rakesh Kumar
The optimization of imidazo[1,2-a]pyridine inhibitors as potent and selective inhibitors of IGF-1R is presented. Further optimization of oral exposure in mice is also discussed. Detailed selectivity, in vitro activity, and in vivo PK profiles of an optimized compound is also highlighted.
Archive | 2003
Stanley D. Chamberlain; Mui Cheung; Holly Kathleen Emerson; Neil W. Johnson; Kristen E. Nailor; Douglas Mccord Sammond; Marcus Semones
Bioorganic & Medicinal Chemistry Letters | 2005
Douglas Mccord Sammond; Kristen E. Nailor; James M. Veal; Robert T. Nolte; Liping Wang; Victoria B. Knick; Sharon K. Rudolph; Anne T. Truesdale; Eldridge N. Nartey; Jeffrey A. Stafford; Rakesh Kumar; Mui Cheung
Archive | 2008
Kevin Kuntz; David E. Uehling; Alex G. Waterson; Kyle Allen Emmitte; Kirk L. Stevens; John Brad Shotwell; Stephon C. Smith; Kristen E. Nailor; James Michael Salovich; Brian John Wilson; Mui Cheung; Robert A. Mook; Erich W. Baum; Ganesh S. Moorthy
Cancer Research | 2007
Kevin Wayne Kuntz; James Michael Salovich; Robert A. Mook; Kyle Allen Emmitte; Stanley D. Chamberlain; Tara Renae Rheault; Keith R. Hornberger; Holly Kathleen Emerson; Stephon C. Smith; Brian John Wilson; Ronda G. Davis-Ward; Kelly Horne Donaldson; George M. Adjabeng; Kristen E. Nailor; Daniel F. Hassler; Gary K. Smith; Timothy J. Lansing; Derek Duckett; Victoria B. Knick; Randy T. McConnell; Jeffrey Jackson; Mui Cheung
Bioorganic & Medicinal Chemistry Letters | 2009
Kyle Allen Emmitte; George M. Adjabeng; C. Webb Andrews; Jennifer G. Badiang Alberti; Ramesh Bambal; Stanley D. Chamberlain; Ronda G. Davis-Ward; Hamilton D. Dickson; Daniel F. Hassler; Keith R. Hornberger; Jeffrey R. Jackson; Kevin Wayne Kuntz; Timothy J. Lansing; Robert A. Mook; Kristen E. Nailor; Mark Andrew Pobanz; Stephon C. Smith; Chiu-Mei Sung; Mui Cheung
publisher | None
author
Archive | 2007
Stanley D. Chamberlain; Mui Cheung; Holly Kathleen Emerson; Neil W. Johnson; Kristen E. Nailor; Douglas Mccord Sammond; Marcus Semones